Information
Joslin eNewsletters
Categories
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
High Hopes Fund
Tag Archives: diabetes research
Who Said Bigger is Better?
It is not just insulin pumps that keep getting smaller and more intelligent. Researchers have started to experiment with nanotherapeutics as a way to prevent and treat type 1 diabetes. Clinical trials for this technology may be years away, but … Continue reading
Clinical Trial Compares Leading-Edge Treatments for Obesity and Diabetes
Recent studies suggest that bariatric surgery (which promotes weight loss by restricting the body’s ability to take in and process nutrients) may lead to impressive resolutions or even cures for many with type 2 diabetes. Continue reading
Posted in Research
Tagged Diabetes obesity, diabetes research, Joslin Diabetes Research, Type 2 Diabetes
2 Comments
TJMaxx Partners with Joslin Diabetes Center to Benefit the High Hopes Fund
We just received a reminder from the folks in the Joslin Diabetes Center Development Office. They’re the folks who work hard all year to raise the money needed to support Joslin’s work in diabetes research and clinical care. From January … Continue reading
The Real Lessons from ACCORD
By Richard Jackson, MD Director of Medical Affairs Healthcare Services, and Strategic Initiatives Joslin Diabetes Center We keep hearing about the recently published ACCORD study, and how tight blood glucose control might not be that important — or even risky. … Continue reading
Posted in Diabetes Day2Day
Tagged ACCORD study, diabetes news, diabetes research, glucose control, Type 2 Diabetes
3 Comments


